KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsNon-Current DebtNon-Current Deffered RevenueOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Regeneron Pharmaceuticals (REGN) Non-Current Assets (2016 - 2025)

Historic Non-Current Assets for Regeneron Pharmaceuticals (REGN) over the last 17 years, with Q4 2025 value amounting to $22.5 billion.

  • Regeneron Pharmaceuticals' Non-Current Assets rose 1800.3% to $22.5 billion in Q4 2025 from the same period last year, while for Dec 2025 it was $86.1 billion, marking a year-over-year increase of 2345.23%. This contributed to the annual value of $22.5 billion for FY2025, which is 1800.3% up from last year.
  • According to the latest figures from Q4 2025, Regeneron Pharmaceuticals' Non-Current Assets is $22.5 billion, which was up 1800.3% from $22.2 billion recorded in Q3 2025.
  • In the past 5 years, Regeneron Pharmaceuticals' Non-Current Assets registered a high of $22.5 billion during Q4 2025, and its lowest value of $7.7 billion during Q1 2021.
  • Moreover, its 5-year median value for Non-Current Assets was $13.6 billion (2023), whereas its average is $14.8 billion.
  • Its Non-Current Assets has fluctuated over the past 5 years, first surged by 5605.21% in 2022, then surged by 202.99% in 2023.
  • Quarter analysis of 5 years shows Regeneron Pharmaceuticals' Non-Current Assets stood at $11.4 billion in 2021, then rose by 16.73% to $13.3 billion in 2022, then rose by 2.03% to $13.6 billion in 2023, then soared by 40.42% to $19.1 billion in 2024, then increased by 18.0% to $22.5 billion in 2025.
  • Its Non-Current Assets stands at $22.5 billion for Q4 2025, versus $22.2 billion for Q3 2025 and $21.4 billion for Q2 2025.